JASLEEN KAUR KHANUJA
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology SCOTTSDALE, AZ NPI 1871936799
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology AZ Sumitomo Pharma America, Inc. All categories
General Payments — all program years on this page
$9,668.92
- Category: General Payments
- Program years: PY2018–2024
- Record count: 349
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,485.85 across 58 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,485.85 | 58 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Sumitomo Pharma America, Inc. | $277.04 | 2 |
| ABBVIE INC. | $191.98 | 11 |
| PFIZER INC. | $161.73 | 8 |
| PUMA BIOTECHNOLOGY, INC. | $134.10 | 6 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $92.09 | 5 |
| GENZYME CORPORATION | $57.62 | 2 |
| Genentech USA, Inc. | $56.53 | 2 |
| Merck Sharp & Dohme Corporation | $55.09 | 2 |
| Genmab U.S., Inc. | $53.55 | 2 |
| Mirati Therapeutics, Inc. | $50.10 | 3 |
| E.R. Squibb & Sons, L.L.C. | $45.43 | 2 |
| Acerta Pharma LLC | $34.42 | 1 |
| Incyte Corporation | $29.91 | 1 |
| Rigel Pharmaceuticals, Inc. | $28.96 | 1 |
| Lilly USA, LLC | $27.55 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $26.38 | 1 |
| Stemline Therapeutics Inc. | $25.82 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $24.99 | 1 |
| ARRAY BIOPHARMA INC | $22.55 | 1 |
| Janssen Biotech, Inc. | $22.47 | 1 |
| GlaxoSmithKline, LLC. | $20.95 | 1 |
| SOBI, INC | $16.28 | 1 |
| Celgene Corporation | $15.23 | 1 |
| Coherus Biosciences Inc. | $15.08 | 1 |
By program year
Records — PY2024 (58)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.